CUTANEOUS T-CELL LYMPHOMA
Clinical trials for CUTANEOUS T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take aim at tough lymphomas in groundbreaking trial
Disease control OngoingThis study is testing a new type of personalized cell therapy for adults whose CD30+ lymphomas have come back or not responded to standard treatments. Doctors take a patient's own immune cells (T cells), genetically modify them to better find and attack cancer cells, and then inf…
Matched conditions: CUTANEOUS T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug tested for Tough-to-Treat skin cancer
Disease control OngoingThis study is testing how well and how safe the drug mogamulizumab is for Chinese adults with advanced forms of a rare skin cancer called cutaneous T-cell lymphoma. The drug is given through an IV to people whose cancer has continued to grow despite at least one prior treatment. …
Matched conditions: CUTANEOUS T-CELL LYMPHOMA
Phase: PHASE4 • Sponsor: Kyowa Kirin China Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC